March 7, 2017 / 2:22 PM / 5 months ago

BRIEF-Novelion Therapeutics says U.S. Patent Trial, appeal board issued written decision in inter partes review proceeding

March 7 (Reuters) - Novelion Therapeutics Inc:

* Novelion Therapeutics - U.S. patent trial, appeal board issued written decision in inter partes review proceeding

* Novelion Therapeutics Inc - ptab affirms patentability of all claims on U.S. 7,932,268 and U.S. 8,618,135 lomitapide dosage regimen patents Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below